Circadian modulation by time-restricted feeding rescues brain pathology and improves memory in mouse models of Alzheimer's disease.

[1]  Julie A. Harris,et al.  Novel App knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia , 2022, Molecular neurodegeneration.

[2]  K. Hoyt,et al.  Circadian clocks, cognition, and Alzheimer’s disease: synaptic mechanisms, signaling effectors, and chronotherapeutics , 2022, Molecular neurodegeneration.

[3]  P. Xu,et al.  Circadian alignment of early onset caloric restriction promotes longevity in male C57BL/6J mice , 2022, Science.

[4]  Justus M. Kebschull,et al.  Hyperexcitable arousal circuits drive sleep instability during aging , 2022, Science.

[5]  Yool Lee,et al.  Multi-Modal Regulation of Circadian Physiology by Interactive Features of Biological Clocks , 2021, Biology.

[6]  Jun Pyo Kim,et al.  BMI1 is associated with CSF amyloid-β and rates of cognitive decline in Alzheimer’s disease , 2021, Alzheimer's Research & Therapy.

[7]  C. Colwell.  Defining circadian disruption in neurodegenerative disorders. , 2021, The Journal of clinical investigation.

[8]  S. Panda,et al.  Time-restricted eating for the prevention and management of metabolic diseases. , 2021, Endocrine reviews.

[9]  Fan Gao,et al.  The role of orexin in Alzheimer disease: From sleep-wake disturbance to therapeutic target , 2021, Neuroscience Letters.

[10]  S. Salatino,et al.  Distinct regulation of hippocampal neuroplasticity and ciliary genes by corticosteroid receptors , 2021, Nature Communications.

[11]  J. Weuve,et al.  Population estimate of people with clinical Alzheimer's disease and mild cognitive impairment in the United States (2020–2060) , 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[12]  L. McMahon,et al.  Heightened Hippocampal β-Adrenergic Receptor Function Drives Synaptic Potentiation and Supports Learning and Memory in the TgF344-AD Rat Model during Prodromal Alzheimer's Disease , 2021, The Journal of Neuroscience.

[13]  J. Gamsby,et al.  The Molecular Clock and Neurodegenerative Disease: A Stressful Time , 2021, Frontiers in Molecular Biosciences.

[14]  P. Sassone-Corsi,et al.  Communicating clocks shape circadian homeostasis , 2021, Science.

[15]  A. Videnovic,et al.  Circadian and Sleep Dysfunctions in Neurodegenerative Disorders—An Update , 2021, Frontiers in Neuroscience.

[16]  D. Bennett,et al.  Circadian disturbances in Alzheimer’s disease progression: a prospective observational cohort study of community-based older adults , 2020, The Lancet. Healthy longevity.

[17]  P. Baldi,et al.  Reshaping circadian metabolism in the suprachiasmatic nucleus and prefrontal cortex by nutritional challenge , 2020, Proceedings of the National Academy of Sciences.

[18]  M. Dallas,et al.  TLR2 and TLR4-mediated inflammation in Alzheimer’s disease: self-defense or sabotage? , 2020, Neural regeneration research.

[19]  P. Baldi,et al.  The circadian dynamics of the hippocampal transcriptome and proteome is altered in experimental temporal lobe epilepsy , 2020, Science Advances.

[20]  J. Hawley,et al.  Time-restricted feeding alters lipid and amino acid metabolite rhythmicity without perturbing clock gene expression , 2020, Nature Communications.

[21]  Christine T. O. Nguyen,et al.  Retinal Functional and Structural Changes in the 5xFAD Mouse Model of Alzheimer’s Disease , 2020, Frontiers in Neuroscience.

[22]  James A. Eddy,et al.  Meta-Analysis of the Alzheimer’s Disease Human Brain Transcriptome and Functional Dissection in Mouse Models , 2020, Cell reports.

[23]  Sungkwon Chung,et al.  Preferred Endocytosis of Amyloid Precursor Protein from Cholesterol-Enriched Lipid Raft Microdomains , 2020, bioRxiv.

[24]  C. Masters,et al.  Total Aβ42/Aβ40 ratio in plasma predicts amyloid-PET status, independent of clinical AD diagnosis , 2020, Neurology.

[25]  J. Strosznajder,et al.  The Novel Role of PPAR Alpha in the Brain: Promising Target in Therapy of Alzheimer’s Disease and Other Neurodegenerative Disorders , 2020, Neurochemical Research.

[26]  M. Maes,et al.  Nutritional ketosis as an intervention to relieve astrogliosis: Possible therapeutic applications in the treatment of neurodegenerative and neuroprogressive disorders , 2020, European Psychiatry.

[27]  B. Platt,et al.  Decay in Retinoic Acid Signaling in Varied Models of Alzheimer’s Disease and In-Vitro Test of Novel Retinoic Acid Receptor Ligands (RAR-Ms) to Regulate Protective Genes , 2019, Journal of Alzheimer's disease : JAD.

[28]  P. Deyn,et al.  Sleep architecture changes in the APP23 mouse model manifest at onset of cognitive deficits , 2019, Behavioural Brain Research.

[29]  O. Shimoni,et al.  A longitudinal assessment of retinal function and structure in the APP/PS1 transgenic mouse model of Alzheimer’s disease , 2019, Translational Neurodegeneration.

[30]  Hye-Jin Kim,et al.  Histone demethylase PHF2 activates CREB and promotes memory consolidation , 2019, EMBO reports.

[31]  Jie Zhu,et al.  Roles of Neuropeptide Y in Neurodegenerative and Neuroimmune Diseases , 2019, Front. Neurosci..

[32]  D. Holtzman,et al.  Bidirectional relationship between sleep and Alzheimer’s disease: role of amyloid, tau, and other factors , 2019, Neuropsychopharmacology.

[33]  F. Saravia,et al.  Periodic dietary restriction ameliorates amyloid pathology and cognitive impairment in PDAPP-J20 mice: Potential implication of glial autophagy , 2019, Neurobiology of Disease.

[34]  Benjamin A. Logsdon,et al.  A novel systems biology approach to evaluate mouse models of late-onset Alzheimer’s disease , 2019, Molecular Neurodegeneration.

[35]  D. Welsh,et al.  Effects of BMAL1 Manipulation on the Brain’s Master Circadian Clock and Behavior , 2019, The Yale journal of biology and medicine.

[36]  E. Ravussin,et al.  Early Time-Restricted Feeding Improves 24-Hour Glucose Levels and Affects Markers of the Circadian Clock, Aging, and Autophagy in Humans , 2019, Nutrients.

[37]  J. Hogenesch,et al.  A database of tissue-specific rhythmically expressed human genes has potential applications in circadian medicine , 2018, Science Translational Medicine.

[38]  P. Baldi,et al.  Epigenetic regulation of the circadian gene Per1 contributes to age-related changes in hippocampal memory , 2018, Nature Communications.

[39]  C. Colwell,et al.  Circadian-based Treatment Strategy Effective in the BACHD Mouse Model of Huntington’s Disease , 2018, Journal of biological rhythms.

[40]  Hai-Bin Ruan,et al.  Ketone bodies as epigenetic modifiers , 2018, Current opinion in clinical nutrition and metabolic care.

[41]  J. Adjaye,et al.  Modeling Late-Onset Sporadic Alzheimer's Disease through BMI1 Deficiency. , 2018, Cell reports.

[42]  David M Holtzman,et al.  Circadian Rest-Activity Pattern Changes in Aging and Preclinical Alzheimer Disease , 2018, JAMA neurology.

[43]  C. Colwell,et al.  Time-Restricted Feeding Improves Circadian Dysfunction as well as Motor Symptoms in the Q175 Mouse Model of Huntington’s Disease , 2018, eNeuro.

[44]  Arch G Mainous,et al.  Flipping the Metabolic Switch: Understanding and Applying Health Benefits of Fasting , 2017, Obesity.

[45]  Lindsay M Lueptow,et al.  Novel Object Recognition Test for the Investigation of Learning and Memory in Mice. , 2017, Journal of visualized experiments : JoVE.

[46]  C. Masters,et al.  Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individuals , 2017, Alzheimer's & dementia.

[47]  M. McCarthy,et al.  Circadian alterations during early stages of Alzheimer's disease are associated with aberrant cycles of DNA methylation in BMAL1 , 2017, Alzheimer's & Dementia.

[48]  L. McMahon,et al.  GSK3 activity regulates rhythms in hippocampal clock gene expression and synaptic plasticity , 2017, Hippocampus.

[49]  C. La Morgia,et al.  Retinal Ganglion Cells and Circadian Rhythms in Alzheimer’s Disease, Parkinson’s Disease, and Beyond , 2017, Front. Neurol..

[50]  C. Colwell,et al.  Blue light therapy improves circadian dysfunction as well as motor symptoms in two mouse models of Huntington's disease , 2017, Neurobiology of sleep and circadian rhythms.

[51]  E. E. Zhang,et al.  Orexin signaling regulates both the hippocampal clock and the circadian oscillation of Alzheimer’s disease-risk genes , 2016, Scientific Reports.

[52]  Patrick Danaher,et al.  Gene expression markers of Tumor Infiltrating Leukocytes , 2016, Journal of Immunotherapy for Cancer.

[53]  D. Holtzman,et al.  Sleep in Alzheimer's Disease–Beyond Amyloid , 2016, Neurobiology of sleep and circadian rhythms.

[54]  K. Blennow,et al.  Plasma β-amyloid in Alzheimer’s disease and vascular disease , 2016, Scientific Reports.

[55]  G. Landreth,et al.  Aβ Extraction from Murine Brain Homogenates. , 2016, Bio-protocol.

[56]  S. Groshen,et al.  A Periodic Diet that Mimics Fasting Promotes Multi-System Regeneration, Enhanced Cognitive Performance, and Healthspan. , 2015, Cell metabolism.

[57]  Satchidananda Panda,et al.  Time-restricted feeding is a preventative and therapeutic intervention against diverse nutritional challenges. , 2014, Cell metabolism.

[58]  Kristine Yaffe,et al.  Connections between sleep and cognition in older adults , 2014, The Lancet Neurology.

[59]  Lihong Chen,et al.  PPARs Integrate the Mammalian Clock and Energy Metabolism , 2014, PPAR research.

[60]  S. Shibata,et al.  Chronobiology and nutrition , 2013, Neuroscience.

[61]  C. Colwell,et al.  The Q175 Mouse Model of Huntington’s Disease Shows Gene Dosage- and Age-Related Decline in Circadian Rhythms of Activity and Sleep , 2013, PloS one.

[62]  Satchidananda Panda,et al.  Time-restricted feeding without reducing caloric intake prevents metabolic diseases in mice fed a high-fat diet. , 2012, Cell metabolism.

[63]  P. Fraering,et al.  Alzheimer's Disease-Linked Mutations in Presenilin-1 Result in a Drastic Loss of Activity in Purified γ-Secretase Complexes , 2012, PloS one.

[64]  G. Bernier,et al.  Bmi1 Is Down-Regulated in the Aging Brain and Displays Antioxidant and Protective Activities in Neurons , 2012, PloS one.

[65]  S. Peirson,et al.  Rapid Assessment of Sleep-Wake Behavior in Mice , 2012, Journal of biological rhythms.

[66]  R. Mistlberger,et al.  Entrainment of circadian clocks in mammals by arousal and food. , 2011, Essays in biochemistry.

[67]  J. Grutzendler,et al.  Multicolor time-stamp reveals the dynamics and toxicity of amyloid deposition , 2011, Scientific reports.

[68]  Sean J. Miller,et al.  Characterization of a Drosophila Alzheimer's Disease Model: Pharmacological Rescue of Cognitive Defects , 2011, PloS one.

[69]  J. Jhamandas,et al.  Interaction between hypothalamic dorsomedial nucleus and the suprachiasmatic nucleus determines intensity of food anticipatory behavior , 2011, Proceedings of the National Academy of Sciences.

[70]  Joseph S. Takahashi,et al.  Circadian Integration of Metabolism and Energetics , 2010, Science.

[71]  S. Fernando,et al.  The Transcriptional Repressor ID2 Can Interact with the Canonical Clock Components CLOCK and BMAL1 and Mediate Inhibitory Effects on mPer1 Expression* , 2010, The Journal of Biological Chemistry.

[72]  David K Welsh,et al.  Suprachiasmatic nucleus: cell autonomy and network properties. , 2010, Annual review of physiology.

[73]  L. Coolen,et al.  Bidirectional interactions between the circadian and reward systems: is restricted food access a unique zeitgeber? , 2009, The European journal of neuroscience.

[74]  Szymon M. Kielbasa,et al.  Regulation of Clock-Controlled Genes in Mammals , 2009, PloS one.

[75]  M. Stoeckli,et al.  Dynamics of Aβ Turnover and Deposition in Different β-Amyloid Precursor Protein Transgenic Mouse Models Following γ-Secretase Inhibition , 2008, Journal of Pharmacology and Experimental Therapeutics.

[76]  Kim N. Green,et al.  Intracellular amyloid-β in Alzheimer's disease , 2007, Nature Reviews Neuroscience.

[77]  Dimitris N. Metaxas,et al.  Novel method for high-throughput phenotyping of sleep in mice. , 2007, Physiological genomics.

[78]  F. van Leuven,et al.  A ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of Alzheimer's disease , 2005, Nutrition & metabolism.

[79]  Judy Mastick,et al.  Effect of morning bright light treatment for rest–activity disruption in institutionalized patients with severe Alzheimer's disease , 2005, International Psychogeriatrics.

[80]  M. Staufenbiel,et al.  APP23 Mice as a Model of Alzheimer's Disease: An Example of a Transgenic Approach to Modeling a CNS Disorder , 2005, CNS Spectrums.

[81]  M. Mattson,et al.  Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[82]  B. Hyman,et al.  Imaging Aβ Plaques in Living Transgenic Mice with Multiphoton Microscopy and Methoxy‐X04, a Systemically Administered Congo Red Derivative , 2002, Journal of neuropathology and experimental neurology.

[83]  F. Stephan,et al.  The “Other” Circadian System: Food as a Zeitgeber , 2002, Journal of biological rhythms.

[84]  G L Wenk,et al.  Assessment of Spatial Memory , 1999, Current protocols in toxicology.

[85]  Uwe Redlin,et al.  The circadian Clock mutant mouse: impaired masking response to light , 2004, Journal of Comparative Physiology A.